.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dani Flinkman

Turku / FI

Turku Bioscience, University Of Turku And Åbo Akademi

Vortrag

Mi., 23.10.
Poster presentation
P-III-1023
Investigation of Parkinson's disease heterogeneity and driving factors based on DIA proteomics analysis of patient PBMCs
Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)

Weitere Beteiligungen

Mi., 23.10.
Poster presentation
P-III-1023
Investigation of Parkinson's disease heterogeneity and driving factors based on DIA proteomics analysis of patient PBMCs
Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)